Royal Bank Of Canada Ocular Therapeutix, Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 18,721 shares of OCUL stock, worth $159,128. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,721

Previous 17,167 9.05%

Holding current value

$159,128

Previous $117,000 38.46%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.45 - $9.23 $10,023 - $14,343	1,554 Added 9.05%	18,721 $162,000
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $61,227 - $126,682	14,578 Added 563.07%	17,167 $117,000
Q1 2024 Nov 05, 2024	SELL	$3.85 - $10.93 $56,125 - $159,337	-14,578 Reduced 84.92%	2,589 $23,000
Q1 2024 May 15, 2024	SELL	$3.85 - $10.93 $82,786 - $235,027	-21,503 Reduced 89.25%	2,589 $23,000
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $303,014 - $658,473	-145,680 Reduced 85.81%	24,092 $107,000
Q3 2023 Nov 14, 2023	BUY	$3.14 - $5.04 $14,811 - $23,773	4,717 Added 2.86%	169,772 $533,000
Q2 2023 Aug 14, 2023	SELL	$4.6 - $7.64 $88,582 - $147,123	-19,257 Reduced 10.45%	165,055 $851,000
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $488,088 - $1.1 Million	174,942 Added 1867.04%	184,312 $971,000
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $10,784 - $18,222	4,132 Added 78.89%	9,370 $26,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $17,603 - $27,976	4,304 Added 460.81%	5,238 $22,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $5.22 $203,503 - $352,918	-67,609 Reduced 98.64%	934 $4,000
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $99,633 - $151,615	-20,628 Reduced 23.13%	68,543 $339,000
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $48,627 - $95,280	7,894 Added 9.71%	89,171 $622,000
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $31,835 - $47,063	3,282 Added 4.21%	81,277 $812,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $1.05 Million - $1.49 Million	77,995 New	77,995 $1.11 Million

Others Institutions Holding OCUL

# of Institutions

171

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Ocular Therapeutix, Inc Transaction History